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ORIGINAL ARTICLE
Intrahepatic persistent fetal right umbilical vein: a retrospective study
Paolo Toscanoa,b, Gabriele Sacconea,b , Lavinia Di Meglioa,b, Letizia Di Meglioa,b, Enrica Mastantuonia,b,
Carla Riccardia,b, Antonio Raffonea, Fulvio Zulloa, Mariavittoria Loccia and Aniello Di Meglioa,b
aDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples “Federico II”, Naples,
Italy; bDiagnostica Ecografica e Prenatale di A. Di Meglio, Naples, Italy
ABSTRACT
Introduction: To appraise the incidence and value of intrahepatic persistent right umbilical
vein (PRUV).
Methods: This was a single-center study. Records of all women with a prenatal diagnosis of
intrahepatic PRUV were reviewed. The inclusion criteria were women with gestational age
greater than 13weeks of gestation. Exclusion criteria were fetuses with situs abnormalities, due
to the hepatic venous ambiguity, and extrahepatic PRUV. The primary outcome was the inci-
dence of intrahepatic PRUV in our cohort. The secondary outcomes were associated
malformations.
Results: 219/57,079 cases (0.38%) of intrahepatic PRUV were recorded. The mean gestational
age at diagnosis was 21.8 ±2.9weeks of gestations. PRUV was isolated in the 76.7%, while in
23.3% was associated with other major or minor abnormalities. The most common associated
abnormalities were cardiovascular abnormalities (8.7%), followed by genitourinary abnormalities
(6.4%), skeletal abnormalities (4.6%), and central nervous system abnormalities (4.1%). Within
the cardiovascular abnormalities, the most common one was ventricular septal defect (six cases).
Conclusion: In most cases PRUV is an isolated finding. Associated minor or major malformations
are presented in the 23.3% of the cases, so this finding should prompt detailed prenatal assess-
ment of the fetus, with particular regard to cardiovascular system.
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Introduction
Persistent right umbilical vein (PRUV) is a pathologic
vascular anomaly occurring in embryonic development
in which the right umbilical vein persists, and the left
vein is occluded. PRUV is the most common anomalies
of the Porto-umbilical system [1].
The estimated frequency of PRUV is about 1 in
250–1250 [2]. This anomaly can occur in an isolated
form, representing a variant of normality, or can be
associated to other major or minor anomalies. The
presence of a PRUV can be assessed in the transverse
section of the fetal abdomen during routine scan. The
umbilical vein courses laterally and to the right of the
gallbladder, where it may then fuze with the right por-
tal vein, which courses toward the stomach, in the so-
called intrahepatic variant. In the extrahepatic variant,
associated with agenesis of ductus venosus (DV), the
umbilical vein drains into the right atrium, infracardiac
portion of the inferior vena cava, or iliac veins [1,3].
Case series on intrahepatic PRUV published so far
included small number of cases, and a recent
systematic review by Lide et al. of all published stud-
ies included 16 articles for a total of only 240 cases of
intrahepatic PRUV [4]. Therefore, the exact incidence
and the clinical significance of intrahepatic PRUV is
not well known. The primary endpoint of this study is
to appraise the incidence and significance of intrahe-
patic PRUV in a retrospective single-center study.
Materials and methods
Study design and participants
This was a single-center retrospective study. Clinical
records of all consecutive pregnant women with a pre-
natal diagnosis of intrahepatic PRUV, who were
referred to our Center (Diagnostica Ecografica e
Prenatale di A. Di Meglio, Naples, Italy), were included
in this study.
The inclusion criteria were pregnant women with
gestational age greater than 13weeks of gestation.
Exclusion criteria were fetuses with situs abnormalities,
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due to the hepatic venous ambiguity, and extrahepatic
PRUV.
The diagnosis of intrahepatic PRUV was based on
the following criteria [4]:
1. Situs solitus
2. Curving of the intrahepatic portion of UV toward
fetal left in the standard abdominal circumference
plane using gray scale 2D and color Doppler
3. Medial relation of the gall bladder with the UV,
between PRUV and stomach
In all cases of PRUV, a detailed anatomy scan was
performed, including fetal echocardiography. The sta-
tus of the DV was also documented in all the cases.
Outcomes
The primary outcome was the incidence of intrahe-
patic PRUV in our cohort. The secondary outcomes
were associated malformations, including cardiovascu-
lar abnormalities, and incidence of chromosomal
abnormalities.
Statistical analysis was performed using Statistical
Package for Social Sciences (SPSS) v. 19.0.
Results
From January 2000 to January 2019, out of the
57,079-s trimester ultrasound scans performed, 219
cases (0.38%) of intrahepatic PRUV, and 5 cases
(0.01%) of extrahepatic PRUV with agenesis of DV,
were recorded. The vast majority of intrahepatic PRUV
were singleton pregnancies (93.6%), 12 were twins,
and 2 were triplets. In all the 14 cases of multiple ges-
tations, only one fetus was affected. The mean gesta-
tional age at diagnosis was 21.8 ± 2.9weeks of
gestations, ranging from 13 to 25weeks (Table 1).
PRUV was isolated in the 76.7% of the cases, while
in 51 cases (23.3%) was associated with other major or
minor abnormalities (Table 2). The most common
associated abnormalities were cardiovascular
abnormalities, reported in the 8.7% of the cases, fol-
lowed by genitourinary abnormalities (6.4%), skeletal
abnormalities (4.6%), and central nervous system
abnormalities (4.1%). Within the cardiovascular abnor-
malities, the most common one, was ventricular septal
defect, reported in six cases (Table 3). Single umbilical
artery was noticed in 8 cases (3.7%). Only four preg-
nancies (1.8%) had chromosomal abnormalities, includ-
ing one 47, XXX; one T(9;13) balanced translocation;
one partial monosomy 9p; and one inversion of
chromosome 3.
Table 1. Characteristics of the included women.
N¼ 219
Age 31.6 ± 4.9
Gravidity 1.7 ± 0.9
Singletons 205 (93.6%)
Twins 12 (5.5%)
Triplets 2 (0.9%)
IVF 4 (1.8%)
Gestational age at diagnosis 21.8 ± 2.9
Data are presented as number (percentage) or as mean ± stan-
dard deviation.
IVF: in vitro fertilization.
Table 2. Associated abnormalities.
N¼ 219
Isolated 168 (76.7%)
Overall associated abnormalities 51 (23.3%)
Central nervous system associated abnormalities
Overall 9 (4.1%)
Agenesis corpus callosum 1 (0.5%)
Colpocephaly 1 (0.5%)
Hydrocephalus 3 (1.4%)
Cerebellar Hypoplasia 3 (1.4%)
Lissencephaly 1 (0.5%)
Choroid plexus cysts 2 (0.91%)
Cord associated abnormalities
Single umbilical artery 8 (3.7%)
Genitourinary associated abnormalities
Overall 14 (6.4%)
Unilateral renal agenesis 2 (0.9%)
Hydronephrosis 7 (3.2%)
Cloacal exstrophy 1 (0.5%)
Bladder exstrophy 1 (0.5%)
Multicystic dysplastic kidney (MCDK) 2 (0.9%)
Hyperechogenic kidneys 1 (0.5%)
Gastroenteric associated abnormalities
Overall 6 (2.7%)
Duodenal atresia 2 (0.9%)
Calcification of glissonian capsule 2 (0.9%)
Hyperechogenic bowel 3 (1.4%)
Stasis Liver 1 (0.5%)
Skeletal abnormalities
Overall 10 (4.6%)
Unilateral club foot 1 (0.5%)
Bilateral club foot 4 (1.8%)
Bilateral agenesis upper limbs 1 (0.5%)
Sacral hypoplasia 1 (0.5%)
Transverse hemimelia lower limb 1 (0.5%)
Humeral hypoplasia with absent radius 1 (0.5%)
Brachydactyly 1 (0.5%)
Thorax abnormalities
Overall 3 (1.4%)
Diaphragmatic hernia 1 (0.5%)
Lung hypoplasia 1 (0.5%)
Pleural effusion 1 (0.5%)
Face abnormalities
Overall 4 (1.8%)
Cleft lip 2 (0.9%)
Micrognathia 1 (0.5%)
Hypotelorism 1 (0.5%)
Hypoplasia nasal bone 1 (0.5%)
Genital abnormalities
Hypogenitalism 1 (0.5%)
Chromosomal abnormalities
Overall 4 (1.8%)
47, XXX 1 (0.5%)
T(9;13) balanced translocation 1 (0.5%)
Partial monosomy 9p 1 (0.5%)
Inversion chromosome 3 1 (0.5%)
Data are presented as number (percentage).
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Discussion
Main findings
In our cohort, the prevalence of intrahepatic PRUV
was 0.38%. In the majority of the cases, PRUV was not
associated with major or minor abnormalities, i.e. was
isolated. Associated minor or major malformations are
presented in the 23.3% of the cases, with the cardio-
vascular abnormalities being the most common associ-
ated malformations. PRUV was rarely associated with
chromosomal abnormalities, being reported in only
1.8% of the cases. This cohort may be the largest
population of fetuses with intrahepatic PRUV pub-
lished so far.
Prior studies have been published on intrahepatic
PRUV (Table 4) [4–17]. A recent systematic review [4],
included 240 cases of intrahepatic PRUV. The overall
prevalence of intrahepatic PRUV was found to be 212
per 166,548 (0.13%). Of the 240 cases of an PRUV
identified by the review, 183 (76.3%) were isolated. In
23.7% of the cases, the authors found minor or major
abnormalities, including 19 cardiac abnormalities
(7.9%), 9 cases of malformations in the central nervous
system (3.8%), 15 cases of abnormalities in the genito-
urinary system (6.3%), 17 cases (7%) of placental or
cord abnormalities, and only three women (1.3%) with
genetic abnormalities [4]. Three more studies have
been published after the systematic review [5–7].
Krzy_zanowski et al. reported on 12 cases of PRUV [5].
They reported an incidence of PRUV of 0.5% (12/
2360), with vast majority of the cases (9 cases, 75%)
showing PRUV as an isolated finding with favorable
prognosis [5]. In referral centers, the prevalence of
fetuses with anomalies is usually increased, and this
may explain the higher prevalence of PRUV in our
cohort. In prior published studies the prevalence of
intrahepatic PRUV ranged from 0.03% to 0.51%, with a
mean of 0.13% (Table 4).
Adiego-Calvo et al. found 56 records of PRUV, with
an overall rate of associated malformation of 17.9%
[6]. Kumar et al. found 23 records of PRUV, with an
incidence of associated malformation of 52.2%, with
cardiovascular malformations being the most common
ones [7].
Implications
At the end of the seventh week of gestation, when
the embryo is about 6mm long, the right umbilical
vein has normally disappeared [18]. Two types of
PRUV have been described in literature. In the type 1,
the intrahepatic form, the right umbilical vein is con-
nected to the portal system and the DV is present. In
the type 2, the extrahepatic form, the right umbilical
vein “jumps” completely the hepatic circulation going
to connect directly to the inferior vena cava or to the
right atrium.
According with our findings, the prevalence of
intrahepatic PRUV was about 0.4%, with an incidence
of associated malformation of 23.3%. Although the
diagnosis of PRUV can be made by using the B-mode,
the routine use of Color-Doppler in the transverse
abdominal section may avoid a missing diagnosis. The
routine use of Color-Doppler in the transverse abdom-
inal section during the second trimester routine anat-
omy scan may explain the higher prevalence of PRUV
in our cohort compared to prior published studies.
Conclusions
In summary, in the majority of cases intrahepatic PRUV
was isolated with no minor or major associated abnor-
malities. Associated minor or major malformations are
Table 3. Incidence of cardiovascular abnormalities.
N¼ 219
Overall 19 (8.7%)
Ventricular septal defect 6 (2.7%)
Atrioventricular canal 3 (1.4%)
Tetralogy of fallot 1 (0.5%)
Right aortic arch 1 (0.5%)
Dextrocardia 1 (0.5%)
Aberrant left subclavian artery 1 (0.5%)
Aberrant right subclavian artery 1 (0.5%)
Atrial septal defect 1 (0.5%)
Hypoplastic left heart 2 (0.9%)
Transposition of the great arteries 1 (0.5%)
Persistent left superior vena cava 1 (0.5%)
Interrupted inferior vena cava with azygos continuation 2 (0.9%)
Dysplastic tricuspid valve 2 (0.9%)
Pericardial effusion 3 (1.4%)
Abdominal aortic aneurysm 1 (0.5%)
Heart failure 1 (0.5%)
Fetal arrhythmias 2 (0.9%)
Aortic valve stenosis 1 (0.5%)
Data are presented as number (percentage).
Table 4. Reported prevalence of intrahepatic persistent right
umbilical vein, studies published since 1994.
Reported prevalence
Hill 1994 [14] 33/15,237 (0.22%)
Kinare 1996 [16] 8/5,754 (0.14%)
Blazer 2000 [13] 69/30,240 (0.22%)
Wolman 2002 [12] 17/8,950 (0.19%)
Viora 2004 [17] 9/34,410 (0.03%)
Yang 2007 [11] 6/1,302 (0.46%)
Weichert 2011 [10] 39/46,653 (0.08%)
Leal 2012 [15] 9/3,576 (0.25%)
Martinez 2013 [9] 22/20,426 (0.11%)
Adiego-Calvo 2016 [6] 56/43,149 (0.13%)
Kumar 2016 [7] 23/20,452 (0.11%)
Krzy_zanowski 2019 [5] 12/2,360 (0.51%)
Total 303/232,509 (0.13%)
Toscano 2019 219/57,079 (0.38%)
Total including our cohort 522/289,588 (0.18%)
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presented in the 23.3% of the cases, so this finding
should prompt detailed prenatal assessment of the
fetus, with particular regard to cardiovascular system.
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